Back
Triumph Financial, Inc. Vs. Sensei Biotherapeutics, Inc. Industry Stock Comparison
Sell
39
TFIN
Triumph Financial, Inc.
Last Price:
$59.97
Seasonality Move:
-3.01%
Buy
53
SNSE
Sensei Biotherapeutics, Inc.
Last Price:
$31.00
Seasonality Move:
-15.96%
Sell
39
Triumph Financial, Inc. (TFIN)
is a Sell
Is Triumph Financial, Inc. a Buy, Sell or Hold?
-
The current Triumph Financial, Inc. [TFIN] share price is $59.95. The Score for TFIN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
TFIN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sensei Biotherapeutics, Inc. (SNSE)
is a Buy
Is Sensei Biotherapeutics, Inc. a Buy, Sell or Hold?
-
The current Sensei Biotherapeutics, Inc. [SNSE] share price is $31.02. The Score for SNSE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
SNSE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TFIN Stock Price Chart
What is Triumph Financial, Inc.'s stock price today?
-
The Triumph Financial, Inc. share price today is $59.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TFIN is experiencing slight buying pressure.
SNSE Stock Price Chart
What is Sensei Biotherapeutics, Inc.'s stock price today?
-
The Sensei Biotherapeutics, Inc. share price today is $31.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNSE is experiencing selling pressure, which indicates risk of future bearish movement.
TFIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 54.33 | Buy |
| Chaikin Money Flow: | 28039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.98 - 59.56) | Buy |
| Bollinger Bands (100): | (55.61 - 66.17) | Sell |
SNSE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.69 | Buy |
| Relative Strength Index (14 RSI): | 55.12 | Buy |
| Chaikin Money Flow: | -41445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.37 - 32.07) | Buy |
| Bollinger Bands (100): | (6.22 - 26.08) | Buy |
TFIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.2 | Buy |
| 20-day SMA: | 57.43 | Buy |
| 50-day SMA: | 61.1 | Sell |
| 200-day SMA: | 58.96 | Buy |
| 8-day EMA: | 58.5 | Buy |
| 20-day EMA: | 58.27 | Buy |
| 50-day EMA: | 59.75 | Buy |
| 200-day EMA: | 61.03 | Sell |
SNSE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.56 | Buy |
| 20-day SMA: | 30.21 | Buy |
| 50-day SMA: | 22.89 | Buy |
| 200-day SMA: | 12.53 | Buy |
| 8-day EMA: | 30.49 | Buy |
| 20-day EMA: | 29.45 | Buy |
| 50-day EMA: | 24.58 | Buy |
| 200-day EMA: | 15.17 | Buy |
Triumph Financial, Inc. Earnings Growth & TFIN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.95 per share, and an increase next year of $1.01 per share.
Sensei Biotherapeutics, Inc. Earnings Growth & SNSE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.73 per share, and a decrease next year of $0.00 per share.
Triumph Financial, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sensei Biotherapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||